“…In the first category (Table 2A) are studies evaluating hemodynamic, metabolic, and hormonal changes associated with brain death and the effects of brain death on donor organ function 19‐25 or pharmacologic interventions to mitigate the adverse effects of brain death 26,27 . Similarly, DCD large animal models have been developed to evaluate the impact of warm ischemia on organ donor function 28‐30 . In the second category (Table 2B) are studies that evaluate experimental methods of DBD graft preservation and technical and pharmacological modifications of DCD graft recovery 17,31,32,33,34,35,36,37,38,39,40,41 .…”